76th ANNUAL ASRM CONGRESS, Oregon, United States Of America, 19 - 21 October 2020, pp.458
Poor ovarian response (POR) accounts for 15% of all assisted reproductive technologies (ART) cycles performed in 2017 and 2018 in the United States, and is associated with increased rate of cycle cancellation, lower number of embryos available for transfer, and overall lower pregnancy rates. Platelet-rich plasma (PRP) is rich in growth factors and cytokines and has been used as an agent that induces tissue regeneration. PRP also promotes follicle development in vitro and has been utilized in small case series as a potential treatment for women with POR. The aim of the current study was to characterize ovarian reserve parameters and IVF outcomes in patients with POR treated with intraovarian injection of autologous PRP.